4//SEC Filing
Carter Robert Ross 4
Accession 0001628280-25-027205
CIK 0001799191other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 2:12 PM ET
Size
5.0 KB
Accession
0001628280-25-027205
Insider Transaction Report
Form 4
Carter Robert Ross
Chief Financial Officer
Transactions
- Disposition to Issuer
Class A Common Stock
2025-05-21$2.67/sh−1,601$4,283→ 235,174 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0002039341
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 2:12 PM ET
- Size
- 5.0 KB